Correlation Between Guangdong Cellwise and Shandong Sanyuan

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Guangdong Cellwise and Shandong Sanyuan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guangdong Cellwise and Shandong Sanyuan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guangdong Cellwise Microelectronics and Shandong Sanyuan Biotechnology, you can compare the effects of market volatilities on Guangdong Cellwise and Shandong Sanyuan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guangdong Cellwise with a short position of Shandong Sanyuan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guangdong Cellwise and Shandong Sanyuan.

Diversification Opportunities for Guangdong Cellwise and Shandong Sanyuan

0.5
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Guangdong and Shandong is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Guangdong Cellwise Microelectr and Shandong Sanyuan Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shandong Sanyuan Bio and Guangdong Cellwise is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guangdong Cellwise Microelectronics are associated (or correlated) with Shandong Sanyuan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shandong Sanyuan Bio has no effect on the direction of Guangdong Cellwise i.e., Guangdong Cellwise and Shandong Sanyuan go up and down completely randomly.

Pair Corralation between Guangdong Cellwise and Shandong Sanyuan

Assuming the 90 days trading horizon Guangdong Cellwise Microelectronics is expected to generate 1.73 times more return on investment than Shandong Sanyuan. However, Guangdong Cellwise is 1.73 times more volatile than Shandong Sanyuan Biotechnology. It trades about 0.01 of its potential returns per unit of risk. Shandong Sanyuan Biotechnology is currently generating about -0.02 per unit of risk. If you would invest  4,914  in Guangdong Cellwise Microelectronics on October 16, 2024 and sell it today you would lose (409.00) from holding Guangdong Cellwise Microelectronics or give up 8.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Guangdong Cellwise Microelectr  vs.  Shandong Sanyuan Biotechnology

 Performance 
       Timeline  
Guangdong Cellwise 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Guangdong Cellwise Microelectronics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Guangdong Cellwise may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Shandong Sanyuan Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shandong Sanyuan Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Shandong Sanyuan is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Guangdong Cellwise and Shandong Sanyuan Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Guangdong Cellwise and Shandong Sanyuan

The main advantage of trading using opposite Guangdong Cellwise and Shandong Sanyuan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guangdong Cellwise position performs unexpectedly, Shandong Sanyuan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shandong Sanyuan will offset losses from the drop in Shandong Sanyuan's long position.
The idea behind Guangdong Cellwise Microelectronics and Shandong Sanyuan Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance